Breaking News, Collaborations & Alliances

Cellect Completes FasL Scale-Up

Upgrade to the development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier

Cellect Biotechnology has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier.  Based on its process and the results of the ongoing clinical trial, the company has scaled up manufacturing of FasL for hundreds of personal batches fully scalable to hundreds of thousands of batches for clinical and collaborative purposes. The company expects to form an alliance of clinical and commercial cell therapy centers using the ApoGraft t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters